MINK THERAPEUTICS INC
INKT·603693102·UQ·Common Stock·Healthcare - Biotechnology
INKT (MINK THERAPEUTICS INC) is held by 18 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($802,635), DnB Asset Management AS ($644,610), GEODE CAPITAL MANAGEMENT, LLC ($182,077). Net institutional sentiment: Bullish.
18
Holders
(2 Elite)
$2.2M
Total Value
71% (14)
Consensus
10 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Sep 2, 2026 · Activists none · Congress none
InsiderWUWIINBERG ULFVest 1K shSep 1, 2026
InsiderCBCorvese BrianVest 2K shSep 1, 2026
InsiderRBRyan BarbaraVest 2K shSep 1, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer